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ABSTRACT 
Cys-loop receptors are pentameric ligand-
gated ion channels that facilitate communication 
within the nervous system. Upon neurotransmitter 
binding, these receptors undergo an allosteric 
activation mechanism connecting the binding 
event to the membrane-spanning channel pore, 
which expands to conduct ions. Some of the 
earliest steps in this activation mechanism are 
carried out by residues proximal to the binding 
site, the relative positioning of which may reflect 
functional differences among members of the Cys-
loop family of receptors. Herein, we investigated 
key side-chain interactions near the binding site 
via mutagenesis and two-electrode voltage-clamp 
electrophysiology in serotonin-gated 5-HT3A 
receptors (5-HT3ARs) and nicotinic acetylcholine 
receptors (nAChRs) expressed in Xenopus laevis 
oocytes. We found that a triad of residues aligning 
to Thr-152, Glu-209, and Lys-211 in the 5-HT3AR 
can be exchanged between the homomeric 5-
HT3AR and the muscle-type nAChR α-subunit 
with small functional consequences. Via triple 
mutant cycle analysis, we demonstrated that this 
triad forms an interdependent network in the 
muscle-type nAChR. Further, nAChR-type 
mutations of the 5-HT3AR affect the affinity of 
nicotine, a competitive antagonist of 5-HT3ARs, in 
a cooperative manner. Using mutant cycle 
analyses between the 5-HT3A triad, loop A 
residues Asn-101 and Glu-102, ß9 residue Lys-
197, and the channel gate at Thr-257, we observed 
that residues in this region are energetically linked 
to the channel gate and are particularly sensitive to 
mutations that introduce a net positive charge. 
This study expands our understanding of the 
differences and similarities in the activation 
mechanisms of Cys-loop receptors.  
INTRODUCTION 
Cys-loop receptors are the subset of 
pentameric ligand-gated ion channels found in 
vertebrates, and include excitatory nicotinic 
acetylcholine receptors (nAChRs) and serotonin-
activated 5-HT3 receptors (5-HT3Rs), as well as 
inhibitory type A γ-aminobutyric acid receptors 
(GABAARs), and glycine receptors (GlyRs) (1–4). 
The pharmacology of these receptors is quite 
broad, and targeted therapeutics may lead to novel 
treatments for a variety of conditions (5–7). 
The overall structure of Cys-loop 
receptors is highly conserved (8). Each subunit is 
composed of an extracellular domain (ECD) beta 
sandwich, a transmembrane domain (TMD) 
formed by four α-helices (numbered M1-M4), and 
a variable intracellular domain defined primarily 
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by the loop between the M3 and M4 helices. Five 
subunits assemble in a concentric manner to form 
a single receptor. Ligand binding sites are formed 
at subunit interfaces in the ECD by three primary 
(+) face “loops” A-C, and three complementary (-) 
face “loops” D-F. An overall picture of the 
interface between two subunits, as exemplified in 
the crystal structure of the homopentameric 5-
HT3A receptor, is shown in Figure 1A (PDB ID: 
4PIR) (9).  
The advent of complete structures of 
eukaryotic Cys-loop receptors, while generally at 
fairly low resolution, has provided valuable 
guidance for comparing members of the Cys-loop 
receptor family. The present work was motivated 
by the recognition of a triad of residues that are, in 
a global sense, conserved across several members 
of the family. Our primary focus has been on the 
homopentameric 5-HT3AR, for which the residues 
of interest are T152, E209, and K211 (Figure 1A; 
numbering as in the crystal structure; these have 
been referred to elsewhere at T179, E236, and 
K238). The structurally aligning residues in the α-
subunits of the recently reported heteromeric α4ß2 
nAChR (PDB ID 5KXI) (10) are K145, D200, and 
T202, while those in the ß3 GABAA 
homopentamer are E153, R207, and S209 (PDB 
ID 4COF) (11). In each triad, there is a cationic 
residue (K/R), an anionic residue (D/E), and a 
residue with an alcohol side chain (S/T). However, 
the relative positioning of these functionalities 
varies among these receptors, which led us to ask 
whether the arrangement reflects differences 
among receptors. To facilitate comparison, we 
have designated the three sites as A, B, and C 
(Figure 1A). A sequence alignment (Figure 1B) 
illustrates the conservation of these arrangements 
within individual receptor subfamilies in humans. 
Note that there are exceptions in the α5 and α10 
nAChR subunits, however these particular α-
subunits do not contribute to the primary binding 
face of nAChRs (1). The α8 nAChR subunit was 
excluded because it is not found in mammals (1). 
Herein we evaluate the functional role of 
this triad in two excitatory Cys-loop receptors – 
the 5-HT3AR and the muscle-type ((α1)2ß1γδ) 
nAChR – using two-electrode voltage clamp 
electrophysiology of mutant receptors expressed in 
Xenopus laevis oocytes. We find that the 5HT3AR 
and nAChR triads can be swapped between these 
two receptors with minimal functional 
consequences. Additionally, substituting the 
nAChR triad into the 5-HT3AR increases the 
affinity for nicotine, demonstrating that this triad 
influences ligand binding. In contrast, swapping 
the triad from the inhibitory GABAAR into the 
5HT3AR does not result in a functional receptor.  
We note from the start that several of the 
residues considered here have been evaluated by 
other investigators, and we have built off that 
work. In muscle-type nAChRs, state-dependent 
interactions have been proposed between K145, 
D200, and Y190 (12–17). The former two residues 
are part of the above-described “triad,” and Y190 
sits on loop C and is part of the aromatic box that 
contributes to the agonist binding site (18, 19). 
The key hydrogen bonding role proposed for 
Y190, however, is not possible in the 5-HT3AR, as 
the aligning residue is F199. As described below, a 
more general interaction between the triad of 
interest and loop A of the agonist binding site is 
seen. Overall, these results highlight similarities 
and variations across members of the Cys-loop 
family. 
RESULTS 
Effects of Exchanging Triads Between 5-
HT3A and the Muscle-type nAChR - To evaluate 
the role of the triad of residues, we used site-
directed mutagenesis to introduce mutations into 
receptors expressed in Xenopus laevis oocytes and 
measured functional responses via dose-response 
relationships using two-electrode voltage clamp 
electrophysiology, as described in Experimental 
Procedures. We generated the 5-HT3AR single 
mutants T152K, E209D and K211T, 
(corresponding to the nAChR residues at sites A, 
B, and C, respectively) as well at the double 
mutants AB, BC, and AC and the triple mutant 
ABC. The dose-response curves measured for all 
of these mutant receptors are compared in Figure 
2A, and the full pharmacological characterization 
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in response to the native agonist serotonin (5-
hydroxytryptamine, or 5-HT) is provided in Table 
1. Representative two-electrode voltage clamp 
traces are provided in Supplemental Figure 1. 
Relative to the wild-type 5-HT3AR, the single 
mutant receptors had EC50 values for serotonin 
that were 39-, 10-, and 1.2-fold greater than wild-
type for A, B, and C, respectively. While the loss 
of function for receptors mutated at the A and B 
sites is clearly meaningful, the consequence of 
mutation at C is not. Note that structurally, 
however, the mutation at site B (Glu to Asp) 
would be expected to be the least perturbing. 
Next, double mutants incorporating each 
of the above three mutations in pairs were 
generated in order to evaluate energetic coupling 
between the mutations via mutant cycle analyses. 
The extent of energetic coupling in a mutant cycle 
analysis is defined as the ∆∆G° value for the 
double mutant, and quantifies the extent to which 
the individual mutations cooperate in the 
activation mechanism of the receptor (20). If 
residues are close enough in space that a direct 
interaction is possible, the ∆∆G° value can also be 
used as a readout of the strength of this interaction.  
The results of the double mutant cycles 
are provided in Table 1. Figure 2B illustrates the 
non-additive effects of the mutations as a 
scatterplot. The AC double-mutant had an EC50 of 
only 2.5 ± 0.05µM 5-HT, a mere 2-fold loss of 
function relative to wild-type (1.3 ± 0.03µM) and 
a 19-fold gain of function relative to the single 
mutant at A (EC50 = 49 ± 1.03µM). Thus, these 
two mutations are strongly energetically coupled, 
with ∆∆G° = 1.8 kcal•mol-1. This and their close 
orientation in space suggest a direct interaction 
between these two residues. The double mutant 
BC showed a much lower coupling energy of 
∆∆G° = 0.49 kcal•mol-1. We consider a two-fold 
deviation from additivity (∆∆G° ≥ 0.40 kcal•mol-1) 
to be meaningful, suggesting that the B and C 
mutations do affect one another, albeit much less 
so than the AC double mutant. Figure 2B 
compares the loss of function for each 
combination of mutations to wild-type 
The double mutant AB was nonfunctional 
up to 800µM 5-HT. In order to meet our criterion 
for a meaningful coupling energy of ≥ 0.40 
kcal•mol-1, the EC50 would either have to be less 
than 200µM if the mutations are meaningfully 
sub-additive or greater than 810µM 5-HT if they 
are superadditive. The effects of the A and B 
mutations are clearly not sub-additive, as we 
observed no response to concentrations of 5-HT 
up to 800µM. It remains possible that the effects 
of these mutations are superadditive. If this were 
the case, we unfortunately could not measure a 
dose-response relationship due to open channel 
block of 5-HT3ARs at high concentrations of 5-HT. 
It is also possible that combining the A and B 
mutations impairs proper folding or trafficking of 
receptors to the cell surface.  
Having generated the single mutants and 
double mutants, we next generated the triple 
mutant 5-HT3AR T152K E209D K211T – “ABC”– 
incorporating all three residues of the nicotinic 
triad. This receptor had only an 8.4-fold increase 
in 5-HT EC50 relative to wild type. Thus, the full 
three-residue swap of nAChR residues into the 
5HT3AR produces functional receptors. In fact, 
EC50 for the triple mutant is comparable to that for 
the single mutation at B and much less than the 
single mutation at A. The increase in EC50 for the 
triple mutant is much less than would be expected 
if the effects of the A, B, and C mutations were 
additive (Fig. 2B).  
Having the triple mutant enables a double 
mutant cycle between the A and B sites in the 
background of the C mutation. This mutant cycle 
has a ∆∆G° = 0.04 kcal•mol-1 (Table 1), 
suggesting that A (T152K) and B (E209D) affect 
the receptor in distinct ways, at least in the 
background of K211T. The triple mutant also had 
somewhat different apparent 
activation/deactivation kinetics than wild-type 
receptors, and a greater extent of open channel 
block at concentrations of 5-HT above those that 
caused a maximal response (Supplemental Figure 
2).  
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We next tested to see how a prototypical 
nAChR, the muscle-type ((α1)2ß1γδ) nAChR, 
would respond when the 5-HT3AR triad was 
introduced. While the most recent nAChR 
structural data are for the α4ß2 neuronal subtype 
(10), we were unable to perform the desired 
experiments in that subtype due to poor expression 
levels. This has been addressed previously (21) by 
introducing the channel pore mutation L9’A, 
however this would complicate our analysis, as the 
residues of interest are involved in receptor gating. 
However, the muscle-type nAChR expresses 
robustly in Xenopus oocytes. The relevant residues 
are the same in the α1 (muscle-type) and α4 
subunits, and they are positioned similarly in the 
cryo-EM structure of the highly homologous 
Torpedo receptor (PDB ID: 2BG9) (22). We 
generated single mutants α1 K145T, D200E, and 
T202K (A, B, and C), and the pharmacological 
responses of these mutants to the native agonist 
acetylcholine (ACh) are summarized in Table 2. 
Representative two-electrode voltage clamp traces 
are provided in Supplemental Figure 3, and 
comparisons of the dose-response relationships 
between the mutant receptors and wild-type can be 
found in Supplemental Figure 4. All mutations 
caused modest losses of function:  4.9-, 2.9-, and 
9.0-fold for A, B, and C, respectively.  
We next generated double mutant pairs in 
the nAChR (Table 2) as described previously for 
the 5-HT3AR. Interestingly, the ∆∆G° values for 
each of the double mutants AB, BC, and AC were 
all near 1.0 kcal•mol-1, indicating a similar degree 
of cooperativity between any two mutations. It is 
not surprising that mutations to K145 and D200 
should be coupled, as previous work has proposed 
a salt bridge between these residues in the muscle-
type nAChR (12). Indeed, analysis via patch 
clamp electrophysiology of the steady-state 
dissociation of ACh from the double mutant 
K145Q D200N has been previously observed to 
give a very similar ∆∆G° value of 1.0 kcal•mol-1, 
and other measures suggest a strong interaction 
between the two (12).  Our observation that both 
residues also couple to T202 suggests interactions 
among all three. 
The next logical step was to evaluate the 
functional response to ACh of the triple mutant:  
α1 K145T D200E T202K (ABC). The triple 
mutant receptor was functional, with EC50 = 67 ± 
5.3µM ACh, a 4.3-fold increase from wild-type 
(Table 2). The data from the single, double, and 
triple mutants enables a triple mutant cycle 
analysis, which can be represented as a cube 
(Figure 3). The difference between each opposite 
face gives a ∆∆∆G°, which quantifies the 
interaction energy among all three residues as a 
unit (23). We find in each case that ∆∆∆G° = 0.95 
kcal•mol-1. That is, any pair of mutations gives 
∆∆G° ≈ 0.95 kcal•mol-1, but in the background of 
any single mutation a double mutant cycle of the 
other two mutations yields ∆∆G° ≈ 0 kcal•mol-1. 
Thus these residues not only interact with one 
another in the activation mechanism, but operate 
as a co-dependent unit in the mouse muscle-type 
nAChR. Each pair of residues is energetically 
dependent on the third residue of the triad.  
To further evaluate the role of this triad, 
we mutated residues in the 5-HT3AR to their 
equivalents in GABAAR ß-subunits, which form 
the primary binding face in GABAARs. The results 
are summarized in Supplemental Table 1. The 
single mutant at the A site (T152E) showed a 10-
fold loss of function, while mutation at the C site 
(K211S) had no functional consequence. The 
single mutant E209R (B site), however, was 
nonfunctional up to 800µM 5-HT. Attempts to 
transplant the entire GABAAR triad into the 5-
HT3AR – T152E E209R K211S – yielded no 
observable response to concentrations of 5-HT as 
high as 800µM. Thus, the inhibitory GABAAR 
appears to behave differently than the excitatory 5-
HT3AR and nAChRs. It is also possible, however, 
that the receptor mutants which did not appear to 
respond to 5-HT were not expressing or not 
reaching the cell surface.  
 Mutating 5-HT3AR Triad to that of the 
nAChR Increases the Binding Affinity of Nicotine - 
Having established that 5-HT3ARs incorporating 
the nAChR-type triad are functional, we next 
evaluated whether residues in the 5-HT3AR triad 
contribute to the pharmacological properties of 
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nicotine, an agonist of most neuronal nAChRs and 
a competitive antagonist of 5HT3ARs (1, 24). To 
accomplish this, we again expressed mutant 5-
HT3ARs incorporating the nicotinic-type mutations 
T152K (A), E209D (B), and K211T (C) as single, 
double, and triple mutants in Xenopus laevis 
oocytes, and generated Schild plots for inhibition 
by nicotine for each receptor variant (25, 26). In 
this procedure, dose-response relationships of each 
receptor variant were measured in the presence of 
different concentrations of nicotine. Higher 
concentrations of nicotine progressively increase 
the EC50 of 5-HT as nicotine displaces 5-HT in the 
orthosteric binding site (Figure 4). In a Schild plot, 
the x-intercept gives a readout of the equilibrium 
dissociation constant (Kd) for the antagonist (25, 
26).   
The Schild plots for each variant are compared to 
that of the wild-type nAChR in Figure 5, the 
parameters of the linear fits are provided in 
Supplemental Table 2, and the full 
pharmacological characterization of the nicotine 
inhibition experiments is provided in 
Supplemental Table 3. The single mutants T152K 
(A), E209D (B), and K211T (C) increased the Kd 
of nicotine by 1.5-, 13-, and 2.5-fold, respectively.  
Meaningful non-additive effects are observed 
when the mutations are combined in the double 
and triple mutants. Despite A and C each 
producing small increases in the Kd of nicotine, the 
double mutant AC is 2.2-fold more sensitive to 
nicotine than wild-type. The double mutant BC is 
more sensitive to inhibition by nicotine than B on 
its own, even though C increases the Kd of 
nicotine on its own. The triple mutant is the most 
nicotine-sensitive of all the variants, with a Kd 5-
fold lower than that of wild-type. Thus these three 
residues influence the binding of nicotine to the 5-
HT3AR. In particular, rearranging of T152 (A-site) 
and K211 (C-site) to their respective positions in 
nAChRs generates variants that are more sensitive 
to nicotine inhibition than wild-type. The mutation 
B, while causing a sizable decrease in nicotine 
affinity on its own, gives a further increase in 
nicotine sensitivity when combined with the A and 
C mutations.  
All this together suggests intimate cooperativity 
between these three residues in regard to nicotine 
binding. Mutant cycles of nicotine Kd values 
(Supplemental Figure 5) illustrate meaningful 
coupling energies between A and C (1.1 kcal•mol-
1), B and C (0.60 kcal•mol-1), and A and B in the 
background of C (1.2 kcal•mol-1).  
We attempted to measure inhibition by 5-
HT of muscle-type nAChRs containing the 5-
HT3AR-type triad. However, the results suggested 
that 5-HT inhibits both wild-type and triple-mutant 
muscle-type nAChRs via a noncompetitive 
mechanism, consistent with previous work (27). 
Maximal currents in the presence of 5-HT were 
decreased, but EC50’s of ACh were unchanged 
(Supplemental Figure 6).  
 The 5-HT3AR Triad is Functionally 
Coupled to Nearby Residues and the Channel 
Gate - Recent structures of Cys-loop receptors 
show that the triad investigated here is near the 
agonist binding site, but none of the residues can 
directly contact a bound agonist (9–11, 15, 17, 28). 
The structures do suggest strong interactions 
between the triad and the canonical “loops” that 
position key residues that directly contribute to 
agonist binding (Supplemental Figure 7). It has 
been previously proposed in the muscle-type 
nAChR that a strong interaction exists between 
K145 and D200 (A-site and B-site) in the closed 
state of the receptor. In the open state this 
interaction was proposed to be weakened by an 
interaction between K145 and the OH of Y190, a 
loop C residue (often referred to as TyrC1) and a 
completely conserved member of the agonist 
binding site aromatic box (12–17). In the α4ß2 
nAChR crystal structure (10), D200 interacts with 
both K145 and T202 (the triad considered here), 
and the OH of Y190 interacts with both K145 and 
D200. Recall the crystal structure most likely 
represents a desensitized state. Very similar 
interactions are seen in the crystal structure of the 
nAChR α2 ECD (28), crystal structures of 
acetylcholine-binding protein (17), and in a 
structure of the α1 subunit ECD (15).  
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In the 5HT3AR the residue that aligns with 
Y190 is F199, which is unable to make the 
hydrogen bonding interaction proposed for Y190 
of the nAChR. Instead, in the crystal structure the 
triad of the 5HT3AR makes no apparent contact 
with loop C, but interacts extensively with N101 
and E102 (9) – residues that are on the A loop of 
the agonist binding site and that have been probed 
previously. Note that N101 aligns with Y93 
(TyrA) of the nAChR, another contributor to the 
aromatic box (18, 19). In particular, T152 (A site) 
interacts with the side chain of E102; E209 (B 
site) interacts with the side chain of N101; and 
there is also an interaction between the backbone 
carbonyl of the A site and the backbone NH of 
N101.The backbone interactions between the A 
site and the A loop is also present in structures of 
the nAChR (10) and GABAAR (11), suggesting an 
interaction between the triad considered here and 
the A loop is a universal feature of Cys-loop 
receptors.  
We have probed the interactions suggested 
by the structural work using mutagenesis. For 
these studies we typically used more conservative 
mutations than were used in the “triad swapping” 
experiments (Table 3). For residues E102 and 
E209, we employ mutations to glutamine and/or 
aspartate; the E102D mutation was not examined 
as it has been observed previously that this 
mutation has little effect on the response of 
receptors to 5-HT (23). We employ a more drastic 
mutation at N101, N101K. This was motivated by 
previous work that demonstrated a high loss of 
function for the N101K mutation (29). For mutant 
cycles with T152, we use the conservative T152V 
mutation. 
Table 3 provides the full characterization 
of the pharmacological response of these receptors 
to 5-HT. There is extensive crosstalk between the 
triad and the residues on loop A. All triad residues 
couple to N101, and K211 couples to E102. Figure 
6 provides a visual depiction of the largest 
coupling energies observed for pairs of mutations 
at the sites shown, including those discussed 
previously and those discussed hereafter. The 
∆∆G° values for different mutant cycles in Figure 
6 are grouped into five categories, each 
representing an additional two-fold deviation from 
additivity.  
Previous work in the 5-HT3AR on loop A 
residues N101 and E102 showed that mutations to 
these residues that introduce a net positive charge 
(N101K and E102Q) generate very large losses of 
function (23, 29). This parallels our observation on 
the T152K mutation, which is the most disruptive 
of the single mutations in the triad swap. We also 
observed a large loss of function for E209Q, 
which likewise introduces a net positive charge. In 
contrast, both K211T and K211M, mutations that 
remove a positive charge, have minimal impacts 
on function, but K211T rescued function of 
receptors with T152K.  
In an effort to further probe this ostensible 
role of positive charge, the single-mutants N101K, 
E102Q, and E209Q, and the double mutants 
N101K/K211T, E102Q/K211T, and E209Q/ 
K211T were evaluated (Figure 7; Table 4). We 
measured ∆∆G° = 0.73, 2.0, and 1.2 kcal•mol-1, 
respectively, for these three double mutant pairs. 
Thus all three pairs of mutations are meaningfully 
coupled, albeit to differing degrees. Recall the 
large coupling (∆∆G° = 1.8 kcal/mol) for 
T152K/K211T.  
We also generated the double mutants 
around the mutation K211M, the reasoning being 
that the nonpolar side chain of methionine is 
sterically similar to the lysine side chain, and does 
not introduce any other functionalities as in the 
case of the threonine hydroxyl in K211T. The 
∆∆G° values observed for the double mutants 
N101K K211M, E102Q K211M, T152K K211M, 
and E209Q K211M were 0.91, 1.7, 0.61, and 1.1 
kcal•mol-1, respectively (Table 4). We also 
generated the double mutant T152V K211M, for 
which the ∆∆G° value was only 0.05kcal•mol-1 
(Table 4), demonstrating that a positive charge 
must be introduced at T152 in order to couple to 
K211. Full dose-response curves for mutant cycles 
examining the role of positive charge among these 
residues are provided in Supplemental Figure 8.  
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Interestingly, each of the mutations that 
introduce a net positive charge couple comparably 
to K211T and K211M, with the exception of 
T152K. This mutation couples strongly to K211T 
(∆∆G° = 1.8 kcal/mol) but more weakly to K211M 
(∆∆G° = 0.61 kcal/mol). That is to say, the K211T 
mutation rescues function of T152K more than 
eight times better than K211M does (Figure 7D). 
We therefore argue that there is a direct interaction 
between T152 and K211 in the 5-HT3AR, the likes 
of which cannot be accounted for by merely 
eliminating the nearby positive charge of the K211 
side chain. On the other hand, the deleterious 
effects of introducing a net positive charge either 
by introducing N101K, E102Q, or E209Q, are 
attenuated whenever the basic amine on K211 is 
removed, regardless of the ability of the residue a 
position 211 to hydrogen bond.  
We also considered another charged 
residue, K197 that seemed a good candidate for 
coupling. In the GABAAR, a functionally 
important salt bridge has been demonstrated 
between residues aligning to K197 and T152 (30). 
The 5-HT3AR mutation K197M couples weakly to 
the nearby E209Q (∆∆G° = 0.65 kcal•mol-1) and 
N101K (∆∆G° = 0.43 kcal/mol), but it does not 
couple meaningfully T152K (∆∆G° = 0.35 
kcal•mol-1) (Table 4).  
Previously, we proposed a strategy for 
evaluating the role of a particular residue in 
channel function by evaluating its coupling to a 
residue in the pore-lining M2 helix that is clearly 
involved in channel gating (31). In the nAChR, 
that residue is termed Leu9’ (the 9th residue from 
the bottom of the M2 helix). In the nAChR we 
found that D200N couples strongly to L9’A (∆∆G 
= 1.3 kcal/mol), establishing a role in gating for 
D200 (32). However, K145Q and T202Tah (Tah = 
α-hydroxy threonine – a backbone mutation) do 
not show strong coupling to L9’A (32).  
In the 5-HT3AR, the appropriate mutation 
is T6’S (T257S in our numbering scheme), which 
has been used extensively to modulate serotonin 
receptor currents (33). We looked for coupling to 
T6’S at N101, E102, T152, and E209. The results 
are summarized in Table 4. We find that N101K, 
E102Q, T152V, and T152K are all meaningfully 
coupled to T6’S, suggesting a role in gating for 
these residues (32). Interestingly, E209D and 
E209Q do not show meaningful coupling to T6’S. 
Thus, the nAChR and the 5-HT3AR show different 
coupling behaviors to the pore-forming M2 helix. 
In the nAChR triad, site B couples but sites A and 
C do not. In the 5-HT3AR site A couples and site B 
does not. We are unable to perform the same 
analysis for mutations to site C, as none of the 
mutations we have studied generates an 
interpretable loss of function relative to wild-type. 
However we do note that mutations to site C 
couple energetically to all of the residues that 
couple to T6’S. 
Attempted expression of the 5-HT3AR 
double mutants E102Q/T152V, E102Q/E209Q, 
N101K/E209Q, and T152K/N101K yielded no 
measurable response to high concentrations of 5-
HT. This may result either from nonfunctional 
receptors or a lack of surface expression. 
Especially for the less-conservative mutations we 
employ, individual mutations likely affect multiple 
interactions involved in receptor function, the 
deleterious effects of which may sometimes add 
together even if other pairs of mutations at the 
same sites generate functional receptors.  
 
Discussion: 
We have identified a triad of residues with 
one cationic, one anionic, and one hydroxyl-
containing side chain that is rearranged between 
the 5-HT3AR, nAChRs, and GABAARs, and 
behaves differently in different receptors. In the 
muscle-type nAChR, the three triad residues 
cooperate as a unit, as demonstrated via triple 
mutant cycle analysis. This corroborates previous 
functional and crystallographic work that 
suggested a salt bridge between two members of 
the triad is involved in receptor gating (10, 12, 15, 
17, 22, 28). We show here that the salt bridge 
between K145 and D200 depends on T202, which 
may coordinate this interaction. Mutant cycles of 
the aligning residues in the 5-HT3AR indicate that 
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T152, E209, and K211 cooperate in the activation 
mechanism of the 5-HT3AR, but not in a perfectly 
codependent manner. Interestingly, the triads of 
the 5-HT3AR and the nAChR can be swapped and 
still produce functional receptors with minimal 
loss of function.  
The triad of residues in the 5-HT3AR 
affects the competitive binding of nicotine for the 
orthosteric site. Each mutation on its own causes a 
decrease in nicotine binding affinity, although the 
shift for T152K is very small. Interestingly 
however, receptor variants with both the T152K 
(A) and K211T (C) mutations saw increases in the 
ability of nicotine to compete with 5-HT relative 
to wild-type receptors. Moreover, E209D (B), 
which causes a large loss of nicotine binding 
affinity on its own, increases the binding affinity 
for the triple mutant ABC relative to double 
mutant AC. These three residues thus cooperate in 
the binding of nicotine, and likely represent a 
characteristic network of nAChRs. Worth noting is 
that the only deviations from the 
cationic/anion/hydroxyl triad of nAChRs are seen 
in the α9 and α10 nAChRs, which are inhibited 
rather than activated by nicotine (34). It has been 
demonstrated elsewhere, however, that mutating 
the α9 Thr to a Lys does not produce receptors that 
are activated by nicotine (35), so there is more to it 
than this one residue.  
The triad from the GABAAR does not 
appear to function in the 5-HT3AR, suggesting this 
network functions differently in GABAARs. Other 
work has proposed a functionally important salt 
bridge between residues in the GABAAR aligning 
to K197 and T152 in the 5-HT3AR (30), however 
we do not observe meaningful functional coupling 
between mutations at these sites in the 5-HT3AR. 
We also note that the pattern of functionalities in 
the triad we have studied is not conserved in 
primary-face α-subunits of inhibitory GlyRs. All 
this together suggests that the triad of residues 
behaves similarly in excitatory receptors, but is 
functionally distinct in inhibitory Cys-loop 
receptors. 
Many amino acid residues we’ve 
considered in this study have been examined 
previously in regard to ligand binding. Based on 
radioligand binding studies of the 5-HT3AR 
antagonist 3H-granisetron, it has been proposed 
that T152 helps to shape the binding site (36). 
Mutations to 5-HT3AR residues E209 and K211 
have been shown previously to have minimal 
effect on binding of 3H-granisetron (29, 36). Our 
results show a minimal effect on nicotine binding 
for T152K, a modest effect for K211T, and a 
sizable effect for E209D. Thus these results 
highlight different binding modes for different 
competitive antagonists.  
We further investigated the involvement 
of residues in the gating mechanism via mutant 
cycle analyses to the channel gate mutation T6’S. 
Loop A residue N101 couples to T6’S, supporting 
a previous proposition that this residue is involved 
in receptor gating (29). The mutation E102Q 
couples to T6’S, in line with a previously-
published result (23). We observe that the T152K 
mutation affects ligand binding and also couples to 
the T6’S; thus we propose that this residue is 
involved in both binding and gating. Quizzically, 
mutant cycles between E209 and T6’S do not 
reveal functional coupling between these residues, 
despite the previously published observation that 
E209 does not participate in the binding of 3H-
granisetron (36). It is possible that E209 plays 
different roles in response to 5-HT versus 
granisetron binding, or that E209 participates in a 
functionally-relevant pathway that is not linked to 
the channel gate at T6’. We have not identified 
any single mutation to K211 that generates 
interpretable shifts in 5-HT EC50, so we were 
unable to perform the same analysis on this 
residue. However, spatially proximal residues that 
couple to the channel gate (N101, E102, and 
T152) also couple to K211. 
Mutations that introduce a net positive 
charge in the region of the 5-HT3AR probed here 
generally increase the 5-HT EC50 by a substantial 
amount. Most of these large losses of function 
could be rescued by mutations that remove the 
side-chain amine of K211. An exception is the 
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highly deleterious T152K mutation, which can be 
rescued by the K211T mutation – corresponding to 
the nAChR swap – but not by the K211M 
mutation. This argues for a highly specific 
interaction between T152 and K211 in the native 
receptor.  
We have demonstrated via mutant cycle 
analyses that triad residues and loop A residues are 
functionally coupled in the 5-HT3AR. Structural 
studies suggest similar interactions between the 
triad and loop A in nAChR. However, a previously 
established interaction between triad residues and 
loop C in nAChRs does not carry over to the 5-
HT3AR. These results highlight the fact that there 
is considerable variation in the degree to which 
structurally/functionally important features are or 
are not conserved across members of the Cys-loop 
family.  
EXPERIMENTAL PROCEDURES 
Molecular biology - The cDNA for the 
mouse 5-HT3R A subunit was in the pGEMhe 
vector. The cDNA for the mouse nAChR α1, ß1, γ, 
and δ were in the pAMV vector. The α1 subunit 
contains a hemagglutinin epitope tag in the M3-
M4 loop, which does not alter the EC50 of ACh. 
Site-directed mutagenesis was performed using a 
QuikChange mutagenesis kit (Stratagene). cDNA 
was linearized using XhoI (New England Biolabs) 
for m5-HT3A, XbaI (New England Biolabs) for 
mα1, or NotI (New England Biolabs) for mß1, mγ, 
and mδ subunits. Linearized DNA was purified 
using a Qiaquick PCR Purification Kit (Qiagen) 
before performing an in vitro runoff transcription 
using a T7 mMessage mMachine kit (Ambion). 
The mRNA was purified using an RNEasy Mini 
Kit (Qiagen) and concentrations were quantified 
via UV-Vis spectroscopy (Nanodrop 2000, 
ThermoFisher Scientific). cDNA was stored at -
20ºC and mRNA was stored at -80ºC.  
Protein expression in Xenopus laevis 
Oocytes - Stage V-VI Xenopus laevis oocytes were 
prepared as previously described (37). Oocytes 
were injected with 50nL of mRNA in nuclease-
free water, and expression levels of different 
mutants were optimized by varying mRNA 
concentrations and incubation times. For 
experiments involving 5-HT3AR variants, oocytes 
were injected with 5-50ng mRNA once at 24h 
before, once at 48h before, or twice at 24h and 48h 
before electrophysiological recording was 
performed. For experiments involving muscle-type 
nAChRs, oocytes were injected with a mixture of 
α1, ß1, γ, and δ mRNAs in a 10:5:5:5ng ratio (per 
50nL) once at 24h before, once at 48h before, or 
twice at 24h and 48h before electrophysiological 
recording was performed. Cells were incubated at 
18ºC in ND96 (96mM NaCl, 2mM KCl, 1mM 
MgCl2, 1.8mM CaCl2, and 5mM HEPES at pH 
7.5) with 0.05mg/mL gentamycin (Sigma 
Aldrich), 2.5mM sodium pyruvate (Acros 
Organics), and 0.67mM theophylline (Sigma 
Aldrich).  
Whole-cell Electrophysiological 
Recording - Electrophysiology and drug perfusion 
were performed at ambient room temperature (20-
25ºC) using the OpusXpress 6000A (Axon 
Instruments) in two-electrode voltage clamp 
(TEVC) mode. Oocytes were impaled with 
borosilicate glass pipettes filled with 3M KCl (R = 
0.3 – 3.0MΩ) and clamped at a holding potential 
of -60mV. Data was sampled at 125Hz. The 
running buffer was Ca2+-free ND96 (96mM NaCl, 
2mM KCl, 1mM MgCl2, and 5mM HEPES at pH 
7.5). Solutions of serotonin hydrochloride (Sigma 
Aldrich), acetylcholine chloride (Sigma Aldrich), 
and (-)-nicotine tartrate (Sigma Aldrich) were 
prepared 0-24h before recording from stock 
solutions stored at -80ºC.  
For dose-response experiments, 1mL of 
each concentration of drug in Ca2+-free ND96 was 
applied for 15s followed by a 116s wash using 
Ca2+-free ND96 before subsequent doses. For 
slow-activating variants, 1mL of drug solution was 
applied for 15s and cells were incubated in the 
drug solution for an additional 15s before washout. 
For slow-deactivating variants, washout times 
were increased to 176s in between doses. The 
different procedure for slow 
activating/deactivating variants did not 
meaningfully change the overall dose-response 
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relationships recorded versus the standard 15s 
application / 116s wash procedure.  
For Schild analysis experiments, cells 
were continuously perfused with Ca2+-free ND96 
containing (-)-nicotine, and 1mL solutions of 5-
HT in Ca2+-free ND96 with the requisite 
concentration of (-)-nicotine were applied for 15s 
per dose, followed by 116s washes in between 
doses. As in the dose-response experiments, 
application times and wash times were adjusted 
for variants displaying slow 
activation/deactivation.  
Data Analysis - Raw TEVC traces were 
prepared and analyzed in Clampfit 10.3 (Axon 
Instruments). Raw data was first filtered using a 
lowpass Gaussian filter at 1Hz. A 30s baseline was 
established prior to each drug application during 
which cells were continuously perfused with Ca2+-
free ND96. The averaged current of the baseline 
was subtracted from the peak amplitude following 
each drug application in order to generate dose-
response data.  
Dose-response data for individual 
concentrations were averaged, plotted, and fit to 
the Hill equation I / Imax = 1 / (1 + (EC50 / 
[agonist]nH) in Kaleidagraph 3.6 (Synergy), where 
EC50 is the concentration for a half-maximal 
response, nH is the Hill coefficient, and I / Imax is 
the normalized response at a given drug 
concentration. For dose-response experiments, 
data were normalized to the maximum current 
observed.  
Dose-response curves shown in figures 
were generated in Prism 7 (GraphPad). The linear 
fit for the Schild plots were determined in Prism 7, 
while the figure itself was made in Microsoft 
Excel 2013. The values for the slopes are reported 
in the text as slope fit ± standard error.  
Coupling energies for double-mutant 
cycles were calculated using the formula ΔΔG = -
R*T*ln((EC50wt*EC50AB) / (EC50A*EC50B)), where 
R is the gas constant, T is temperature, A and B 
denote individual mutations, and AB denotes 
double mutant receptors. The value used for T was 
293.15K.  
The sequence alignment in Figure 1B was 
performed in Clustal Omega using sequences from 
Uniprot corresponding to the following accession 
numbers: P46098 (human 5-HT3A), P02708 
(human α1 nAChR), Q15822 (human α2 nAChR), 
P32297 (human α3 nAChR), P43681 (human α4 
nAChR), P30532 (human α5 nAChR), Q15825 
(human α6 nAChR), P36544, (human α7 nAChR), 
Q9UGM1 (human α9 nAChR), Q9GZZ6 (human 
α10 nAChR), P18505 (human ß1 GABAA), 
P47870 (human ß2 GABAA), P28472 (human ß3 
GABAA).
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(ECD), transmembrane domain (TMD), 5-hydroxytryptamine (5-HT), half-maximal effective 
concentration (EC50), Hill coefficient (nH), Maximal current (Imax), acetylcholine (ACh), half-maximal 
inhibitory concentration (IC50) 
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Table 1 
      Response to 5-HT of 5-HT3ARs incorporating nAChR-type mutations. 
Mutation(s) EC50 (µM) nH |Imax| (µA) Fold  N ΔΔG† 
- 1.3 ± 0.03 2.4 ± 0.11 1.1 - 78 1.0 21 - 
T152K 49 ± 1.03 1.9 ± 0.06 0.14 - 11 39 15 - 
E209D 13 ± 0.20 2.3 ± 0.07 0.53 - 21 10 15 - 
K211T 1.5 ± 0.04 2.9 ± 0.16 1.9 - 25 1.2 15 - 
T152K E209D NR NR NR NR 15 0.04* 
T152K K211T 2.5 ± 0.05 2.1 ± 0.08 1.3 - 56 2.0 14 1.8 
E209D K211T 6.9 ± 0.25 2.1 ± 0.11 0.18 - 12 5.5 16 0.49 
T152K E209D K211T 11 ± 0.39 2.4 ± 0.18 0.15 - 19 8.4 12 - 
†
kcal•mol
-1
; *Measured in the background of K211T; NR = no response; ± indicates SEM. 
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Table 2 
      Response to ACh of muscle-type nAChRs incorporating 5-HT3AR-type mutations. 
Mutation(s) EC50 (µM) nH |Imax| (µA) Fold N ΔΔG† 
- 15 ± 0.08 1.5 ± 0.08 3.6 - 47 - 14 - 
α1 K145T 75 ± 3.6 1.4 ± 0.05 4.0 - 62 4.9 16 - 
α1 D200E 45 ± 0.20 1.2 ± 0.08 0.05 - 0.58 2.9 13 - 
α1 T202K 140 ± 2.5 1.5 ± 0.03 10 - 62 9.0 10 - 
α1 K145T D200E 44 ± 2.4 1.2 ± 0.09 0.08 - 23 2.8 13 0.94 
α1 K145T T202K 110 ± 0.95 1.3 ± 0.04 0.35 - 5.9 7.2 12 1.0 
α1 D200E T202K 82 ± 3.8 1.4 ± 0.08 0.05 - 0.14 5.3 10 0.93 
α1 K145T D200E T202K 67 ± 5.3 1.1 ± 0.06 0.05 - 0.18 4.3 10 - 
†
kcal•mol
-1; ± indicates SEM. 
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Table 3 
      Functional cooperation between triad residues, loop A, K197 (loop C), and the channel gate in mutant 
5-HT3ARs. Table is divided into five sections, from top to bottom: 1. Single mutants, 2. Mutant cycles 
to N101K and T152V, 3. Mutant cycles to the channel gate at T6’, 4. Mutant cycles examining role of 
positive charge, 5. Nonresponsive variants. 
Mutation(s) EC50 (µM) nH |Imax| (µA) Fold N ΔΔG† 
- 1.3 ± 0.03 2.4 ± 0.11 1.0 - 78 1.0 21 - 
N101K 42 ± 1.1 2.4 ± 0.11 0.05 - 5.2 34 14 - 
E102Q 85 ± 3.0 1.6 ± 0.07 0.53 - 5.5 68 15 - 
T152V 8.5 ± 0.27 2.2 ± 0.13 0.42 - 78 6.8 11 - 
T152K 49 ± 1.0 1.9 ± 0.06 0.14 - 11 39 15 - 
K197M 1.5 ± 0.04 2.7 ± 0.19 2.1 - 20 1.2 10 - 
E209D 13 ± 0.20 2.3 ± 0.07 0.53 - 20 10 15 - 
E209Q 93 ± 4.3 2.4 ± 0.21 2.0 - 42 75 22 - 
K211M 2.2 ± 0.05 2.9 ± 0.13 4.9 - 15 1.8 9 - 
K211T 1.5 ± 0.04 2.5 ± 0.16 1.9 - 25 1.2 15 - 
T6'S 1.3 ± 0.01 4.1 ± 0.17 0.26 - 17 1.0 22 - 
N101K T152V 84 ± 4.0 1.8 ± 0.10 7.2 - 17 67 16 0.72 
N101K E209D 29 ± 0.17 2.9 ± 0.04 6.7 - 59 23 17 1.6 
T152V E209D 12 ± 0.21 1.8 ± 0.05 11 - 23 9.5 13 1.1 
T152V E209Q 96 ± 1.5 2.6 ± 0.09 6.1 - 87 76 16 1.0 
N101K T6'S 11 ± 0.29 1.6 ± 0.07 0.30 - 23 8.5 11 0.83 
E102Q T6'S 5.4 ± 0.28 1.4 ± 0.07 0.10 - 3.9 4.3 15 1.6 
T152V T6'S 1.4 ± 0.10 1.3 ± 0.10 2.3 - 50 1.1 10 0.98 
T152K T6'S 6.6 ± 0.27 2.2 ± 0.16 0.13 - 2.3 5.3 11 1.2 
E209D T6'S 12 ± 0.55 1.9 ± 0.14 0.30 - 15 9.9 13 0.05 
E209Q T6'S 73 ± 8.9 1.1 ± 0.09 0.11 - 15 58 15 0.17 
N101K K211M 16 ± 0.31 2.0 ± 0.08 0.15 - 5.5 13 13 0.91 
N101K K211T 15 ± 0.27 3.0 ± 0.16 0.09 - 4.2 12 15 0.73 
E102Q K211M 8.7 ± 0.15 2.2 ± 0.06 0.28 - 18 6.9 15 1.7 
E102Q K211T 3.1 ± 0.06 2.6 ± 0.10 6.6 - 51 2.5 15 2.0 
T152K K211M 31 ± 0.39 2.0 ± 0.04 1.3 - 18 25 15 0.61 
T152K K211T 2.5 ± 0.05 2.1 ± 0.08 1.3 - 56 2.0 14 1.8 
T152V K211M 13 ± 0.19 2.3 ± 0.07 2.2 - 19 10 15 0.05 
E209Q K211M 27 ± 0.28 2.6 ± 0.06 3.2 - 16 21 14 1.1 
E209Q K211T 15 ± 0.37 2.7 ± 0.15 5.0 - 16 12 12 1.2 
K197M E209Q 36 ± 0.24 2.8 ± 0.04 4.6 - 12 29 11 0.65 
N101K K197M 24 ± 1.43 1.9 ± 0.18 0.05 - 0.74 19 12 0.43 
T152K K197M 32 ± 1.30 1.5 ± 0.08 0.08 - 1.8 25 10 0.35 
N101K T152K NR NR NR NR 9 NR 
N101K E209Q NR NR NR NR 16 NR 
E102Q T152V NR NR NR NR 10 NR 
E102Q T152K NR NR NR NR 5 NR 
E102Q E209Q NR NR NR NR 8 NR 
T152K E209D NR NR NR NR 15 NR 
T152K K211T E102Q NR NR NR NR 9 NR 
†kcal•mol-1; NR = no response; ± indicates SEM. 
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FIGURE LEGENDS 
 
Figure 1. Region of interest in this study. A, View of two adjacent receptor subunits from the 5-
HT3AR crystal structure (PDB 4PIR). The inset shows residues mutated in this study highlighted 
in yellow and binding-site residues of the aromatic box shown in green for context; red = 
oxygen, blue = nitrogen. B, Sequence alignment of subunits contributing to the primary binding 
face of human-type 5-HT3ARs, nAChRs, and GABAARs. Cells are colored according to side-
chain chemistry. Unfilled cells indicate non-conservation with regard to the triad in that receptor 
subtype. ECD = extracellular domain; TMD = transmembrane domain; ICD = intracellular 
domain. *Residue numbers corresponding to the 5-HT3AR crystal structure (PDB: 4PIR). See 
Experimental Procedures for sequence accession numbers.  
 
Figure 2. Mutating residues T152, E209, and K211 in 5-HT3ARs to their equivalents in 
nAChRs has non-additive effects on receptor function. A, Dose-response curves of wild-type 
and mutant receptors to 5-HT. Variants are ordered from top to bottom in order of increasing 
EC50. B, Scatterplots illustrating losses of function (±S.D.) of mutants on a logarithmic scale. 
The double mutants and triple mutant display considerable deviations from additivity.   
 
Figure 3. Triple mutant cycle in the muscle-type nAChR. Each face of the cube represents a 
double mutant cycle. Double mutant cycles from wild-type are meaningfully coupled, however 
any pair of mutations is uncoupled in the background of the other mutation of the triad. This 
analysis yields ΔΔΔG = 0.95 kcal•mol-1 for the three mutations. 
 
Figure 4. Dose-response curves of 5-HT3AR variants in the presence of varying 
concentrations of nicotine. As a competitive antagonist, nicotine shifts the dose-response curve 
of 5-HT3ARs to higher EC50 values. Some variants are more sensitive to competitive inhibition 
by nicotine than others. 
 
Figure 5. Schild analysis of inhibition of 5-HT3ARs by nicotine. A-F, Schild plots comparing 
inhibition of the wild-type 5-HT3AR to the mutants T152K, E209D, K211T, T152K K211T, 
E209D K211T, and T152K E209D K211T, respectively. Meaningful changes in nicotine Kd are 
observed, and the mutations have non-additive effects. Error bars are shown as SEM, and are 
often smaller than the data points.  
 
Figure 6. Greatest-magnitude coupling energies observed between pairs of mutations at 
residues in 5-HT3ARs. Full data can be found in Tables 1 and 3. 
 
Figure 7. In 5-HT3ARs, mutations which remove the cationic amine on K211 functionally 
couple to nearby mutations which introduce positive charge. A, Mutant cycles with N101K. 
B, Mutant cycles with E102Q. C, Mutant cycles with E209Q. D, Mutant cycles with T152K. Full 
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pharmacological data can be found in Table 4. Dose-response curves provided in Supplemental 
Figure 8. Error bars represent SD. 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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